Submucous Resection Smr — Cost, Top Hospitals & Success Rates | MyMedicPlus

Submucous Resection (SMR) is a classic ENT surgical procedure designed to correct a deviated nasal septum — the wall of cartilage and bone that divides the nasal cavity into two passages. First described by Freer and Killian in the early 1900s, SMR remains a well-established technique that provides durable relief for patients who cannot breathe properly through their nose.

The septum ideally runs straight down the centre of the nose. When it deviates to one or both sides — whether due to genetics, trauma, or abnormal development — it can obstruct airflow, impair sinus drainage, and cause chronic nasal symptoms. SMR addresses this by removing or repositioning the deflected cartilage and bone beneath the mucosal lining, preserving the overlying mucoperichondrium and mucoperiosteum (the submucous layers), which is why the operation is called submucous resection.

In modern ENT practice, SMR has been largely supplemented by septoplasty, which conserves more cartilage by repositioning rather than removing it. However, SMR is still preferred in cases where cartilage is severely deviated, thickened, or calcified and cannot be adequately corrected by conservative repositioning. Understanding both procedures helps patients and clinicians choose the most appropriate intervention.

The procedure is performed entirely through the nostrils (endonasally) with no external incisions, and typically takes 30–90 minutes under general or local anaesthesia. Most patients return home the same day or after one night in hospital.

SMR is indicated primarily for structural nasal problems caused by a deviated nasal septum, but it may also address related ENT conditions when performed alongside other procedures.

• Deviated Nasal Septum (DNS): The primary indication. A septum that deviates significantly from the midline obstructs one or both nasal passages, reducing airflow. Patients experience nasal congestion, difficulty breathing through the nose, and mouth-breathing — especially during sleep.
• Chronic Nasal Obstruction: Persistent blockage that does not respond to medical therapy (nasal steroids, antihistamines, decongestants) over 3–6 months is a strong indication for surgical correction.
• Recurrent Sinusitis: A deviated septum can impair drainage of the paranasal sinuses, predisposing to recurrent or chronic sinusitis. SMR, often combined with functional endoscopic sinus surgery (FESS), restores normal sinus ventilation.
• Septal Spurs and Ridges: Bony spurs (sharp projections) from the septum may contact the lateral nasal wall, causing headaches, facial pain, and epistaxis (nosebleeds). SMR removes these spurs.
• Obstructive Sleep Apnoea (Nasal Component): While nasal obstruction is rarely the sole cause of OSA, correcting severe septal deviation can reduce apnoea-hypopnoea index and improve CPAP tolerance in affected patients.
• Epistaxis (Recurrent Nosebleeds): Septal deviations cause turbulent airflow that dries the nasal mucosa and precipitates bleeding. SMR reduces this turbulence.
• Anosmia / Hyposmia: Obstruction caused by a deviated septum may impair airflow to the olfactory epithelium, reducing the sense of smell. Restoring nasal patency can improve olfaction.

SMR is contraindicated in children under 17–18 years (before skeletal maturity is complete), in patients with active nasal infection, and in those with bleeding disorders unless corrected pre-operatively.

Patient selection for SMR is based on clinical assessment, symptom severity, and confirmation that nasal obstruction is structural rather than purely inflammatory or mucosal in origin.

Clinical Criteria for Eligibility

• Documented Septal Deviation: Anterior rhinoscopy, nasal endoscopy, or CT scan of the paranasal sinuses confirms significant deviation that correlates with symptoms.
• Failure of Conservative Management: Nasal corticosteroid sprays, antihistamines, saline irrigation, and decongestants have been tried for at least 3 months without adequate relief.
• Age 17 or Older: Septal surgery is generally deferred until facial growth is complete to avoid disrupting cartilaginous development centres. Exceptions exist for severe deformity causing respiratory distress in younger patients.
• Non-Smoker or Smoking Cessation: Smoking impairs mucosal healing and increases the risk of post-operative complications. Surgeons typically advise cessation for at least 4–6 weeks before surgery.
• No Active Infection: Acute sinusitis or rhinitis at the time of surgery increases bleeding risk and risk of spreading infection.
• Adequate Anaesthetic Fitness: Routine pre-operative assessment including blood count, coagulation screen, and anaesthetic review.

Pre-operative Assessment

A thorough ENT examination including nasal endoscopy assesses the degree and type of deviation, identifies coexisting conditions (turbinate hypertrophy, nasal polyps), and helps plan the procedure. CT scanning is requested when sinusitis or complex anatomical variation is suspected. Patients must disclose all medications, particularly blood thinners (aspirin, warfarin, novel oral anticoagulants), which may need to be stopped 5–10 days before surgery.

The classic SMR technique involves creating a mucosal incision, elevating the mucoperichondrial flap, and removing the deviated cartilage and bone under direct vision. Modern refinements have improved outcomes and reduced complications.

Classic Killian-Freer SMR Technique

1. Incision: A hemitransfixion or Killian incision is made just inside one nostril at the caudal end of the septum, through the mucoperichondrium.
2. Flap Elevation: A submucous plane is developed using a Freer elevator, lifting the mucoperichondrium and mucoperiosteum away from the deviated cartilage and bone.
3. Resection: The deviated portions of the quadrilateral cartilage, vomer, and perpendicular plate of the ethmoid are removed, leaving a dorsal and caudal strut of cartilage (typically 1–1.5 cm) to maintain nasal shape and support.
4. Closure: The mucosal flaps are repositioned and sutured or held in place with nasal packs or transseptal sutures.

Septoplasty (Modern Modification)

Septoplasty preserves cartilage by scoring, morselising, and repositioning it rather than removing it wholesale. This conserves nasal support structures and is preferred for younger patients and for deviations amenable to repositioning. Many surgeons use the term "septoplasty" broadly to include elements of SMR, and the procedures overlap considerably in practice.

Endoscopic SMR/Septoplasty

Using a nasal endoscope provides superior illumination and magnification, allowing more precise resection — particularly for posterior septal deviations, spurs, and deviations close to the skull base. Endoscopic techniques have largely replaced headlight-only surgery in specialist centres.

Combined Procedures

SMR is frequently combined with: Turbinate Reduction (inferior turbinoplasty or submucosal diathermy) to address concurrent turbinate hypertrophy; Functional Endoscopic Sinus Surgery (FESS) for coexisting sinusitis; and Rhinoplasty when cosmetic correction of the external nose is also desired (septorhinoplasty).

SMR offers significant and durable improvements for patients with symptomatic nasal septal deviation when medical therapy has failed. The benefits are both functional and quality-of-life-related.

• Restored Nasal Airway: The primary benefit is improved nasal breathing. Studies report 85–90% of patients experience significant or complete relief of nasal obstruction following septoplasty/SMR.
• Improved Sleep Quality: Nasal obstruction is a major driver of mouth-breathing, snoring, and disturbed sleep. Correcting the airway frequently reduces snoring and improves sleep architecture, with many patients reporting feeling more rested post-operatively.
• Reduced Sinusitis Episodes: Restoring normal nasal anatomy and sinus ostial drainage reduces the frequency of acute sinusitis episodes. Patients on chronic antibiotic courses for recurrent sinusitis often achieve freedom from infection after surgery.
• Decreased Epistaxis: Removing bony spurs and smoothing turbulent airflow reduces mucosal drying and recurrent nosebleeds.
• Better CPAP Compliance: For patients with obstructive sleep apnoea who struggle to use CPAP due to nasal obstruction, SMR can improve mask tolerance and therapy adherence.
• Enhanced Sense of Smell: Restoring airflow to the olfactory region can improve the sense of smell in patients where obstruction was the primary cause of hyposmia.
• Long-lasting Results: Unlike decongestant sprays that provide only temporary relief and carry risks of rebound congestion (rhinitis medicamentosa) with prolonged use, surgical correction provides durable structural improvement.
• No External Scarring: The procedure is performed entirely through the nostrils, leaving no visible external scars.

SMR is generally safe when performed by an experienced ENT surgeon, but as with all surgery it carries potential risks. Patients should discuss these in detail with their surgeon before consenting to the procedure.

Common and Minor Complications

• Post-operative Bleeding (Epistaxis): The most common complication, occurring in approximately 1–2% of cases requiring intervention. Minor bleeding managed with packing; rarely requires return to theatre.
• Nasal Crusting and Dryness: Temporary in the first 4–8 weeks post-operatively. Regular saline irrigation and nasal moisturisers manage this effectively.
• Temporary Swelling and Congestion: Mucosal swelling means patients may not notice immediate improvement in breathing for 4–6 weeks while healing occurs.
• Pain and Headache: Mild-to-moderate discomfort managed with regular paracetamol and NSAIDs for the first 5–7 days.

Less Common but Significant Complications

• Septal Haematoma: Accumulation of blood between the mucosal flaps. If untreated, can lead to septal perforation. Recognised by severe nasal pain, swelling, and fever within 24–48 hours post-op. Requires urgent drainage.
• Septal Perforation: A hole in the nasal septum. Occurs in approximately 1% of cases. Small perforations may be asymptomatic; larger ones cause whistling, crusting, bleeding, and difficulty breathing. Repair is technically challenging.
• Infection: Uncommon with prophylactic antibiotics but can occur. Signs include fever, purulent discharge, and increased pain 3–5 days post-operatively.
• Over-resection / Saddle Nose Deformity: Excessive removal of the dorsal or caudal cartilaginous strut can cause collapse of the nasal dorsum ("saddle nose") — a significant cosmetic deformity requiring reconstructive rhinoplasty.
• Change in Nasal Shape: Even without saddle deformity, subtle changes in nasal tip support or dorsal height can occur.
• Persistent Obstruction: Approximately 10–15% of patients report incomplete resolution of symptoms, sometimes due to residual deviation, turbinate hypertrophy, or mucosal disease requiring further treatment.
• Anaesthetic Risks: Standard risks of general or local anaesthesia including allergic reactions, nausea, and rare cardiovascular events.

Recovery from SMR is typically straightforward, though swelling and temporary congestion mean full benefit may not be appreciated for several weeks. Adherence to post-operative instructions is critical for optimal healing.

Immediate Post-operative Period (Days 1–7)

• Nasal packs (if used) are removed within 24–48 hours. Removal may cause brief discomfort.
• Head elevation (sleeping with 2–3 pillows) reduces swelling.
• Cold compresses applied to the bridge of the nose for the first 24 hours minimise bruising and swelling.
• Avoid blowing the nose forcefully for at least 2 weeks. Sneezing should be done with the mouth open.
• Refrain from strenuous activity, bending, or heavy lifting for 2 weeks to reduce bleeding risk.

Nasal Hygiene

Saline nasal douching or irrigation (e.g., with a NeilMed bottle or neti pot) is strongly recommended from day 3–4 post-operatively, 2–3 times daily. This removes dried blood, crusts, and secretions, keeps the healing mucosa moist, and reduces infection risk. Continue for 6–8 weeks or as directed.

Medications

• Analgesia: Paracetamol ± ibuprofen (if no contraindication) for the first 5–7 days.
• Prophylactic antibiotics: Short course as prescribed by the surgeon.
• Topical nasal steroid spray: Often restarted at 2–4 weeks post-operatively to manage mucosal inflammation and optimise nasal airway.

Return to Activity

• Sedentary work: 5–7 days
• Light exercise (walking): 2 weeks
• Contact sports or swimming: 4–6 weeks
• Air travel: Generally safe after 2 weeks, confirm with surgeon

Follow-up Appointments

Typical follow-up schedule: 1–2 weeks (pack removal, wound check), 6 weeks (endoscopic review, assess airway), and 3–6 months (final outcome assessment). Report fever, heavy bleeding, severe pain, or rapidly increasing swelling to your surgeon immediately.

The cost of Submucous Resection varies considerably based on country, hospital setting, surgeon experience, and whether additional procedures are performed simultaneously. Understanding the components of cost helps patients plan effectively.

Global Cost Ranges (Approximate, 2026)

• India: USD 800 – 2,500 (INR 65,000 – 2,00,000) — highly cost-effective with JCI-accredited hospitals available
• Thailand: USD 1,200 – 3,000
• Turkey: USD 1,000 – 2,800
• United Kingdom (NHS): Covered if medically indicated; private: GBP 2,500 – 5,000
• United States: USD 5,000 – 12,000 (facility + surgeon + anaesthesia)
• Australia: AUD 3,000 – 7,000 (partial Medicare rebate may apply)

Key Cost Determinants

• Type of Facility: Day-surgery centres are substantially cheaper than full inpatient hospital admission.
• Anaesthesia: General anaesthesia adds to cost and requires an anaesthetist fee. Local anaesthesia with sedation is less expensive.
• Surgeon's Experience: Subspecialist rhinologists or fellowship-trained ENT surgeons typically charge higher fees but may offer better outcomes for complex cases.
• Combined Procedures: SMR performed alongside turbinate reduction, FESS, or rhinoplasty significantly increases the total cost but may reduce the overall burden versus staged procedures.
• Implants / Grafts: If spreader grafts or cartilage grafts are used for reconstruction, material costs are added.
• Geographic Location: Medical tourism to India, Thailand, or Turkey can achieve savings of 60–80% compared to Western countries without compromising quality at accredited centres.

Insurance Coverage

SMR is generally covered by health insurance when performed for documented functional indications (nasal obstruction, recurrent sinusitis). Purely cosmetic rhinoplasty is excluded. Patients should obtain pre-authorisation and a letter from their ENT surgeon confirming medical necessity before surgery.

Before considering surgery, and alongside it, a range of non-surgical and minimally invasive alternatives should be explored. The choice depends on the severity of deviation, patient preference, and the underlying cause of nasal obstruction.

Non-Surgical Medical Treatments

• Intranasal Corticosteroid Sprays: First-line treatment for nasal obstruction related to allergic rhinitis, vasomotor rhinitis, or mild mucosal swelling. Preparations such as fluticasone, mometasone, and budesonide reduce mucosal oedema effectively. They do not correct structural deformity.
• Antihistamines: Effective for allergic rhinitis component. Available as oral tablets (loratadine, cetirizine, fexofenadine) or intranasal formulations (azelastine).
• Saline Nasal Irrigation: High-volume saline irrigation (e.g., neti pot, squeeze bottle) reduces mucosal inflammation, clears mucus, and improves nasal patency. Safe for long-term daily use and recommended as adjunct therapy.
• Short-course Nasal Decongestants: Oxymetazoline or xylometazoline sprays provide rapid symptomatic relief for acute congestion. Must not be used for more than 5–7 consecutive days due to risk of rebound congestion (rhinitis medicamentosa).
• Nasal Dilators: External nasal strips (e.g., Breathe Right) or internal nasal dilators improve airflow temporarily and are useful during sleep or exercise. They address symptoms without correcting underlying deviation.

Minimally Invasive Alternatives

• Septoplasty: The modern successor to SMR, which preserves cartilage by repositioning rather than wholesale removal. Most ENT surgeons prefer septoplasty over classic SMR for most presentations of septal deviation.
• Radiofrequency Turbinate Reduction: If turbinate hypertrophy is the dominant cause of obstruction rather than septal deviation, radiofrequency ablation of the inferior turbinates is a minimally invasive outpatient option.
• Balloon Sinuplasty: For cases where sinusitis rather than septal deviation is the primary problem, balloon sinuplasty dilates blocked sinus ostia without removing tissue. Not appropriate for structural septal deviation.

The key distinction between alternatives and SMR is that non-surgical treatments manage symptoms without addressing the underlying structural problem. Patients with true structural nasal septal deviation who fail medical therapy are ultimately best served by surgical correction to achieve lasting relief.